Literature DB >> 22359409

Comprehensive care for sickle cell disease immigrant patients: a reproducible model achieving high adherence to minimum standards of care.

Raffaella Colombatti1, Maria Montanaro, Fabiola Guasti, Patrizia Rampazzo, Giorgio Meneghetti, Marco Giordan, Giuseppe Basso, Laura Sainati.   

Abstract

BACKGROUND: Comprehensive care and advances in clinical investigations have reduced morbidity and mortality in sickle cell disease (SCD), but only a minority of children with SCD has access to comprehensive care. In Europe the majority of patients with SCD are immigrants who present barriers in accessing the health system; therefore, new evidence-based models of comprehensive care are needed to ensure that all SCD patients receive high-quality care, overcoming patient- and health system-related barriers. We wanted to verify if addressing the specific needs of immigrant patients contributes to improving adherence. PROCEDURES: Linguistic, cultural, social issues were considered in organizing comprehensive care in 2006. Hospital's records were used to determine access from 2006 to 2010 and to compare adherence before and after 2006.
RESULTS: Ninety-four patients with SCD were enrolled in comprehensive care; 94% were first generation immigrants (81% African). Age at diagnosis was higher for children born abroad vs. children born in Italy (66.08 vs 25.36 months, P < 0.005). Since 2006, children were seen at least once a year, with 100% adherence to follow-up appointments. Coverage increased from 26% to 97% for flu vaccination, from 80% to 92% for pneumococcus immunization, from 27% to 100% for Transcranial Doppler (TCD) screening (P < 0.001). Emergency Department access/patient/year and inpatient admissions/patient/year decreased from 2.3 to 0.98 and from 0.30 to 0.25, respectively (P < 0.001).
CONCLUSIONS: Comprehensive care can be delivered to vulnerable groups obtaining high adherence if linguistic, cultural, social issues are addressed. This model may merit assessment in other communities where immigrants represent the majority of patients.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22359409     DOI: 10.1002/pbc.24110

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  12 in total

Review 1.  Systematic and Meta-Analytic Review: Medication Adherence Among Pediatric Patients With Sickle Cell Disease.

Authors:  Kristin Loiselle; Jennifer L Lee; Lauren Szulczewski; Sarah Drake; Lori E Crosby; Ahna L H Pai
Journal:  J Pediatr Psychol       Date:  2015-09-18

2.  Distribution of HbS Allele and Haplotypes in a Multi-Ethnic Population of Guinea Bissau, West Africa: Implications for Public Health Screening.

Authors:  Maddalena Martella; Mimma Campeggio; Gift Pulè; Ambroise Wonkam; Federica Menzato; Vania Munaretto; Giampietro Viola; Sabado P Da Costa; Giulia Reggiani; Antonia Araujo; Dionisio Cumbà; Giuseppe Liotta; Laura Sainati; Fabio Riccardi; Raffaella Colombatti
Journal:  Front Pediatr       Date:  2022-04-07       Impact factor: 3.569

3.  Coagulation activation in children with sickle cell disease is associated with cerebral small vessel vasculopathy.

Authors:  Raffaella Colombatti; Emiliano De Bon; Antonella Bertomoro; Alessandra Casonato; Elena Pontara; Elisabetta Omenetto; Graziella Saggiorato; Agostino Steffan; Tamara Damian; Giuseppe Cella; Simone Teso; Renzo Manara; Patrizia Rampazzo; Giorgio Meneghetti; Giuseppe Basso; Maria Teresa Sartori; Laura Sainati
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240

4.  An Educational Study Promoting the Delivery of Transcranial Doppler Ultrasound Screening in Paediatric Sickle Cell Disease: A European Multi-Centre Perspective.

Authors:  Baba P D Inusa; Laura Sainati; Corrina MacMahon; Raffaella Colombatti; Maddalena Casale; Silverio Perrotta; Paola Rampazzo; Claire Hemmaway; Soundrie T Padayachee
Journal:  J Clin Med       Date:  2019-12-24       Impact factor: 4.241

5.  Patterns and patient factors associated with loss to follow-up in the Muhimbili sickle cell cohort, Tanzania.

Authors:  Upendo Masamu; Raphael Z Sangeda; Daniel Kandonga; Jesca Ondengo; Flora Ndobho; Bruno Mmbando; Siana Nkya; Khadija Msami; Julie Makani
Journal:  BMC Health Serv Res       Date:  2020-12-14       Impact factor: 2.655

6.  Intellectual function evaluation of first generation immigrant children with sickle cell disease: the role of language and sociodemographic factors.

Authors:  Maria Montanaro; Raffaella Colombatti; Marisa Pugliese; Camilla Migliozzi; Fabiana Zani; Maria Elena Guerzoni; Sheila Manoli; Renzo Manara; Giorgio Meneghetti; Patrizia Rampazzo; Francesca Cavalleri; Marco Giordan; Paolo Paolucci; Giuseppe Basso; Giovanni Palazzi; Laura Sainati
Journal:  Ital J Pediatr       Date:  2013-06-04       Impact factor: 2.638

7.  Global migration and the changing distribution of sickle haemoglobin: a quantitative study of temporal trends between 1960 and 2000.

Authors:  Frédéric B Piel; Andrew J Tatem; Zhuojie Huang; Sunetra Gupta; Thomas N Williams; David J Weatherall
Journal:  Lancet Glob Health       Date:  2014-02       Impact factor: 26.763

8.  Organizing national responses for rare blood disorders: the Italian experience with sickle cell disease in childhood.

Authors:  Raffaella Colombatti; Silverio Perrotta; Piera Samperi; Maddalena Casale; Nicoletta Masera; Giovanni Palazzi; Laura Sainati; Giovanna Russo
Journal:  Orphanet J Rare Dis       Date:  2013-10-20       Impact factor: 4.123

9.  Cognition and the Default Mode Network in Children with Sickle Cell Disease: A Resting State Functional MRI Study.

Authors:  Raffaella Colombatti; Marta Lucchetta; Maria Montanaro; Patrizia Rampazzo; Mario Ermani; Giacomo Talenti; Claudio Baracchini; Angela Favero; Giuseppe Basso; Renzo Manara; Laura Sainati
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

10.  Hospitalization Events among Children and Adolescents with Sickle Cell Disease in Basra, Iraq.

Authors:  Zeina A Salman; Meaad K Hassan
Journal:  Anemia       Date:  2015-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.